Glial Fibrillary Acidic Protein: GFAP-Thirty-One Years (1969–2000)

It is now well established that the glial fibrillary acidic protein (GFAP) is the principal 8–9 nm intermediate filament in mature astrocytes of the central nervous system (CNS). Over a decade ago, the value of GFAP as a prototype antigen in nervous tissue identification and as a standard marker for fundamental and applied research at an interdisciplinary level was recognized (Raine, 135). As a member of the cytoskeletal protein family, GFAP is thought to be important in modulating astrocyte motility and shape by providing structural stability to astrocytic processes. In the CNS of higher vertebrates, following injury, either as a result of trauma, disease, genetic disorders, or chemical insult, astrocytes become reactive and respond in a typical manner, termed astrogliosis. Astrogliosis is characterized by rapid synthesis of GFAP and is demonstrated by increase in protein content or by immunostaining with GFAP antibody. In addition to the major application of GFAP antisera for routine use in astrocyte identification in the CNS, the molecular cloning of the mouse gene in 1985 has opened a new and rich realm for GFAP studies. These include antisense, null mice, and numerous promoter studies. Studies showing that mice lacking GFAP are hypersensitive to cervical spinal cord injury caused by sudden acceleration of the head have provided more direct evidence for a structural role of GFAP. While the structural function of GFAP has become more acceptable, the use of GFAP antibodies and promoters continue to be valuable in studying CNS injury, disease, and development.

[1]  R. Liem,et al.  Suppression by antisense mRNA demonstrates a requirement for the glial fibrillary acidic protein in the formation of stable astrocytic processes in response to neurons , 1991, The Journal of cell biology.

[2]  I. Campbell Transgenic mice and cytokine actions in the brain: bridging the gap between structural and functional neuropathology 1 Published on the World Wide Web on 21 October 1997. 1 , 1998, Brain Research Reviews.

[3]  A. Hamberger,et al.  GFAP-deficient astrocytes are capable of stellation in vitro when cocultured with neurons and exhibit a reduced amount of intermediate filaments and an increased cell saturation density. , 1998, Experimental cell research.

[4]  W. A. Day Solubilization of neurofilaments from central nervous system myelinated nerve. , 1977, Journal of ultrastructure research.

[5]  D. Dahl Isolation and initial characterization of glial fibrillary acidic protein from chicken, turtle, frog and fish central nervous systems. , 1976, Biochimica et biophysica acta.

[6]  A. Bignami,et al.  Intermediate filaments in nervous tissue. , 1985, Cell and muscle motility.

[7]  L. Eng,et al.  Dissociation of GFAP intermediate filaments in eae: Observations in the lumbar spinal cord , 1989, Glia.

[8]  D. Bigner,et al.  Study of Glial Fibrillary Acidic Protein in a Human Glioma Cell Line Grown in Culture and as a Solid Tumor , 1983, Journal of neurochemistry.

[9]  W. Schlaepfer,et al.  Calcium-mediated breakdown of glial filaments and neurofilaments in rat optic nerve and spinal cord , 1981, Neurochemical Research.

[10]  A. Privat,et al.  Disrupted glial fibrillary acidic protein network in astrocytes from vimentin knockout mice , 1996, The Journal of cell biology.

[11]  S. Prusiner,et al.  Scrapie in mice deficient in apolipoprotein E or glial fibrillary acidic protein , 1996, Neurology.

[12]  Michaela Brenner Structure and Transcriptional Regulation of the GFAP Gene , 1994, Brain pathology.

[13]  L. Eng,et al.  The protein composition of bovine myelin-free axons. , 1976, Biochimica et biophysica acta.

[14]  L. Eng,et al.  Studies of human and bovine spinal nerve roots and the outgrowth of CNS tissues into the nerve root entry zone , 1979, Brain Research.

[15]  T. Beach,et al.  Patterns of gliosis in alzheimer's disease and aging cerebrum , 1989, Glia.

[16]  M. Aschner,et al.  Transfection and overexpression of metallothionein-I in neonatal rat primary astrocyte cultures and in astrocytoma cells increases their resistance to methylmercury-induced cytotoxicity , 1999, Brain Research.

[17]  S. Lewis,et al.  Temporal Expression of Mouse Glial Fibrillary Acidic Protein mRNA Studied by a Rapid In Situ Hybridization Procedure , 1985, Journal of neurochemistry.

[18]  C. Ackerley,et al.  Characterization of glial filament-cytoskeletal interactions in human astrocytomas: an immuno-ultrastructural analysis. , 1998, European journal of cell biology.

[19]  A. Messing,et al.  Axonal and Nonneuronal Cell Responses to Spinal Cord Injury in Mice Lacking Glial Fibrillary Acidic Protein , 1997, Experimental Neurology.

[20]  S. Yen,et al.  Biochemical correlates of astrocytic proliferation in the mutant Staggerer mouse , 1977, Brain Research.

[21]  Wallace W. Tourtellotte,et al.  Multiple Sclerosis: Pathology, Diagnosis, and Management , 1983 .

[22]  M. Brenner,et al.  Gene therapy in a rodent model of Parkinson's disease using differentiated C6 cells expressing a GFAP-tyrosine hydroxylase transgene. , 1999, Life sciences.

[23]  C. Ackerley,et al.  Co-expression of nestin and vimentin intermediate filaments in invasive human astrocytoma cells , 1999, International Journal of Developmental Neuroscience.

[24]  N. Malamud Neuropathology of Organic Brain Syndromes Associated with Aging , 1972 .

[25]  H. Varmus,et al.  Basic fibroblast growth factor induces cell migration and proliferation after glia-specific gene transfer in mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[26]  A. Bignami,et al.  Preparation of antisera to neurofilament protein from chicken brain and human sciatic nerve , 1977, The Journal of comparative neurology.

[27]  A. Bignami,et al.  Isolation from peripheral nerve of a protein similar to the glial fibrillary acidic protein , 1976, FEBS letters.

[28]  L. Larocca,et al.  Immunocytochemical distribution of S-100 protein in patients with Down's syndrome , 2004, Acta Neuropathologica.

[29]  C. Finch,et al.  Glial Fibrillary Acidic Protein: Regulation by Hormones, Cytokines, and Growth Factors , 1994, Brain pathology.

[30]  N. Sueoka,et al.  Cell‐type specific segregation of transcriptional expression of glial genes in the rat peripheral neurotumor RT4 cell lines , 1993, Journal of neuroscience research.

[31]  C. Brosnan,et al.  Glial Fibrillary Acidic Protein Increases in the Spinal Cord of Lewis Rats with Acute Experimental Autoimmune Encephalomyelitis , 1988, Journal of neurochemistry.

[32]  R. Liem,et al.  Reexpression of glial fibrillary acidic protein rescues the ability of astrocytoma cells to form processes in response to neurons , 1994, The Journal of cell biology.

[33]  J. Goldman,et al.  Fatal encephalopathy with astrocyte inclusions in GFAP transgenic mice. , 1998, The American journal of pathology.

[34]  A. Yu,et al.  Inhibition of GFAP synthesis by antisense RNA in astrocytes , 1991, Journal of neuroscience research.

[35]  Clive N Svendsen,et al.  Leukocyte Infiltration, Neuronal Degeneration, and Neurite Outgrowth after Ablation of Scar-Forming, Reactive Astrocytes in Adult Transgenic Mice , 1999, Neuron.

[36]  S. Brown,et al.  Selective astrocytic transgene expression in vitro and in vivo from the GFAP promoter in a HSV RL1 null mutant vector – potential glioblastoma targeting , 1998, Gene Therapy.

[37]  A. Hamberger,et al.  Altered taurine release following hypotonic stress in astrocytes from mice deficient for GFAP and vimentin. , 1998, Brain research. Molecular brain research.

[38]  P. Burger,et al.  The development of the pathologic changes of Alzheimer's disease and senile dementia in patients with Down's syndrome. , 1973, The American journal of pathology.

[39]  David M. A. Mann,et al.  The pathological association between down syndrome and Alzheimer disease , 1988, Mechanisms of Ageing and Development.

[40]  A. Caruso,et al.  Structural features of the rat GFAP gene and identification of a novel alternative transcript , 1999, Journal of neuroscience research.

[41]  S. DeArmond,et al.  Degradation of glial fibrillary acidic protein protein by a calcium dependent proteinase: an electroblot study , 1983, Brain Research.

[42]  D. Selkoe,et al.  Diffuse senile plaques occur commonly in the cerebellum in Alzheimer's disease. , 1989, The American journal of pathology.

[43]  M. Inagaki,et al.  Glial Fibrillary Acidic Protein: Dynamic Property and Regulation by Phosphorylation , 1994, Brain pathology.

[44]  J. Bigbee,et al.  The role of glial fibrillary acidic protein in the diagnosis of central nervous system tumors , 1978, Acta Neuropathologica.

[45]  A. Messing,et al.  Overexpression of TGF‐β1 in the Central Nervous System of Transgenic Mice Results in Hydrocephalus , 1995, Journal of neuropathology and experimental neurology.

[46]  Y. L. Lee,et al.  Astrocytes cultured from transgenic mice carrying the added human glial fibrillary acidic protein gene contain rosenthal fibers , 1998, Journal of neuroscience research.

[47]  F. M. Sinex,et al.  ON THE RELATIONSHIP OF BRAIN FILAMENTS TO MICROTUBULES 1 , 1974, Journal of neurochemistry.

[48]  Richard F. Thompson,et al.  Deficient Cerebellar Long-Term Depression, Impaired Eyeblink Conditioning, and Normal Motor Coordination in GFAP Mutant Mice , 1996, Neuron.

[49]  M. Brenner,et al.  Astrocyte-specific expression of tyrosine hydroxylase after intracerebral gene transfer induces behavioral recovery in experimental Parkinsonism , 1998, Gene Therapy.

[50]  J. Tinklenberg,et al.  Antigenic profile of plaques and neurofibrillary tangles in the amygdala in Down's syndrome: a comparison with Alzheimer's disease , 1990, Brain Research.

[51]  J. Segovia,et al.  Primary astrocytes retrovirally transduced with a tyrosine hydroxylase transgene driven by a glial‐specific promoter elicit behavioral recovery in experimental Parkinsonism , 2000, Journal of neuroscience research.

[52]  A. Björklund,et al.  Grafts of EGF‐responsive neural stem cells derived from GFAP‐hNGF transgenic mice: Trophic and tropic effects in a rodent model of Huntington's disease , 1997, The Journal of comparative neurology.

[53]  P. Dirks,et al.  Effects of antisense glial fibrillary acidic protein complementary DNA on the growth, invasion, and adhesion of human astrocytoma cells. , 1994, Cancer research.

[54]  T. Mandybur Cerebral amyloid angiopathy and astrocytic gliosis in Alzheimer's disease , 2004, Acta Neuropathologica.

[55]  R. Terry,et al.  Fibrous Astrocytes in Senile Dementia of the Alzheimer Type , 1981, Journal of neuropathology and experimental neurology.

[56]  A. Yu,et al.  Astrogliosis in culture: III. Effect of recombinant retrovirus expressing antisense glial fibrillary acidic protein RNA , 1994, Journal of neuroscience research.

[57]  T. Beach,et al.  Lamina-specific arrangement of astrocytic gliosis and senile plaques in Alzheimer's disease visual cortex , 1988, Brain Research.

[58]  A. Yu,et al.  Astrogliosis in culture: I. The model and the effect of antisense oligonucleotides on glial fibrillary acidic protein synthesis , 1993, Journal of neuroscience research.

[59]  L. Eng,et al.  Localization of the glial fibrillary acidic protein in astrocytes by immunofluorescence. , 1972, Brain research.

[60]  D. Dahl,et al.  Glial fibrillary acidic protein from bovine and rat brain. Degradation in tissues and homogenates. , 1976, Biochimica et biophysica acta.

[61]  O. Paulson,et al.  Blood-brain and blood-spinal cord barrier permeability during the course of experimental allergic encephalomyelitis in the rat , 1984, Brain Research.

[62]  S. Salamat,et al.  Alzheimer's disease: β-amyloid precursor protein expression in plaques varies among cytoarchitectonic areas of the medial temporal lobe , 1991, Neuroscience Letters.

[63]  I. Campbell,et al.  Astrocyte-Targeted Expression of IFN-α1 Protects Mice from Acute Ocular Herpes Simplex Virus Type 1 Infection , 1998, The Journal of Immunology.

[64]  J. D. Smith,et al.  Human apolipoprotein E allele-specific brain expressing transgenic mice , 1998, Neurobiology of Aging.

[65]  A. Messing,et al.  Conditional Ablation of Cerebellar Astrocytes in Postnatal Transgenic Mice , 1996, The Journal of Neuroscience.

[66]  H. Nawashiro,et al.  Mice lacking GFAP are hypersensitive to traumatic cerebrospinal injury , 1998, Neuroreport.

[67]  S. Korey,et al.  Phosphate Buffer Extraction Of Gliosed ALD White Matter , 2003 .

[68]  R. McLendon,et al.  Immunohistochemistry of the Glial Fibrillary Acidic Protein: Basic and Applied Considerations , 1994, Brain pathology.

[69]  J. Roder,et al.  Glial overexpression of NGF enhances neuropathic pain and adrenergic sprouting into DRG following chronic sciatic constriction in mice , 1998, Neuroscience Letters.

[70]  K. Beyreuther,et al.  A4 Protein in Alzheimer's Disease: Primary and Secondary Cellular Events in Extracellular Amyloid Deposition , 1989, Journal of neuropathology and experimental neurology.

[71]  L. Eng,et al.  GFAP and Astrogliosis , 1994, Brain pathology.

[72]  D. Dickson,et al.  Modified Bielschowsky and Immunocytochemical Studies on Cerebellar Plaques in Alzheimer's Disease , 1990, Journal of neuropathology and experimental neurology.

[73]  P. Traub,et al.  Proteolysis of vimentin and desmin by the Ca2+-activated proteinase specific for these intermediate filament proteins , 1983, Molecular and cellular biology.

[74]  M. Eddleston,et al.  Molecular profile of reactive astrocytes—Implications for their role in neurologic disease , 1993, Neuroscience.

[75]  J. Clark,et al.  Glial Fibrillary Acidic Protein in the Cytoskeletal and Soluble Protein Fractions of the Developing Rat Brain , 1987, Journal of neurochemistry.

[76]  A. Fagan,et al.  Glial Fibrillary Acidic Protein–Apolipoprotein E (apoE) Transgenic Mice: Astrocyte-Specific Expression and Differing Biological Effects of Astrocyte-Secreted apoE3 and apoE4 Lipoproteins , 1998, The Journal of Neuroscience.

[77]  H. Wiśniewski,et al.  EFFECTS OF MITOTIC SPINDLE INHIBITORS ON NEUROTUBULES AND NEUROFILAMENTS IN ANTERIOR HORN CELLS , 1968, The Journal of cell biology.

[78]  A. Bignami,et al.  Specificity of the glial fibrillary acidic protein for astroglia. , 1977, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[79]  M. Rapport,et al.  IDENTIFICATION OF GLIAL FIBRILLARY ACIDIC PROTEIN BY THE IMMUNOPEROXIDASE METHOD IN HUMAN BRAIN TUMORS , 1977, Journal of neuropathology and experimental neurology.

[80]  F. Chiu,et al.  Intermediate Filaments from Bovine, Rat, and Human CNS: Mapping Analysis of the Major Proteins , 1980, Journal of neurochemistry.

[81]  A. Bignami,et al.  Immunogenic properties of the glial fibrillary acidic protein , 1976, Brain Research.

[82]  L. Eng,et al.  Immunocytochemical staining for glial fibrillary acidic protein and the metabolism of cytoskeletal proteins in experimental allergic encephalomyelitis , 1983, Brain Research.

[83]  S. DeArmond,et al.  Degradation of glial fibrillary acidic protein by a calcium dependent proteinase: an electroblot study. , 1983, Brain research.

[84]  B. Horten,et al.  Fungal aneurysms of intracranial vessels. , 1976, Archives of neurology.

[85]  A. Lorenzo,et al.  BRAIN VASCULAR PERMEABILITY TO I125 GAMMA GLOBULIN AND LEUKOCYTES IN ALLERGIC ENCEPHALOMYELITIS , 1967, Journal of neuropathology and experimental neurology.

[86]  R. Kucherlapati,et al.  Experimental autoimmune encephalomyelitis in mice lacking glial fibrillary acidic protein is characterized by a more severe clinical course and an infiltrative central nervous system lesion. , 1998, The American journal of pathology.

[87]  C. Betsholtz,et al.  Mice lacking glial fibrillary acidic protein display astrocytes devoid of intermediate filaments but develop and reproduce normally. , 1995, The EMBO journal.

[88]  L. Eng Glial fibrillary acidic protein (GFAP): the major protein of glial intermediate filaments in differentiated astrocytes , 1985, Journal of Neuroimmunology.

[89]  M. Schachner,et al.  Immunological distinction between neurofilament and glial fibrillary acidic proteins by mouse antisera and their immunohistological characterization. , 1978, Developmental neuroscience.

[90]  G. Mancardi,et al.  Fibrous astrocytes in Alzheimer's disease and senile dementia of Alzheimer's type , 2004, Acta Neuropathologica.

[91]  E. Shooter,et al.  Cell-free synthesis of glial fibrillary acidic protein , 1980, Neurochemical Research.

[92]  Steven A. Johnson,et al.  GFAP mRNA increases with age in rat and human brain , 1993, Neurobiology of Aging.

[93]  J. Bigbee,et al.  A PRELIMINARY STUDY OF GLIOMA MORPHOLOGY USING THE PEROXIDASE-ANTI PEEOXIDASE IMMUNOHISTOLOGICAL METHOD FOR GLIAL FIBRILLARY ACIDIC PROTEIN: 125 , 1976 .

[94]  L. Eng,et al.  Contribution of immunohistochemistry to diagnostic problems of human cerebral tumors. , 1978, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[95]  A. Björklund,et al.  Generation and Transplantation of EGF-Responsive Neural Stem Cells Derived from GFAP–hNGF Transgenic Mice , 1997, Experimental Neurology.

[96]  L. Eng,et al.  Immunological study of the glial fibrillary acidic protein. , 1972, Brain research.

[97]  W. Griffin,et al.  Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[98]  R. Pearce,et al.  Targeted deletion in astrocyte intermediate filament (Gfap) alters neuronal physiology. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[99]  S. Salamat,et al.  Alzheimer's disease: beta-amyloid precursor protein expression in plaques varies among cytoarchitectonic areas of the medial temporal lobe. , 1991, Neuroscience Letters.

[100]  M. Peschanski,et al.  Neuritic Outgrowth Associated with Astroglial Phenotypic Changes Induced by Antisense Glial Fibrillary Acidic Protein (GFAP) mRNA in Injured Neuron–Astrocyte Cocultures , 1997, The Journal of Neuroscience.

[101]  M. Schachner,et al.  Biochemistry of the filaments of brain. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[102]  R. Kucherlapati,et al.  GFAP Is Necessary for the Integrity of CNS White Matter Architecture and Long-Term Maintenance of Myelination , 1996, Neuron.

[103]  P. Davison Neuronal fibrillar proteins and axoplasmic transport , 1975, Brain Research.

[104]  M. Rapport,et al.  Glial fibrillary acidic protein and Alzheimer‐type senile dementia , 1980, Neurology.

[105]  H. Wiśniewski,et al.  ON NEUROFILAMENT and NEUROTUBULE PROTEINS FROM HUMAN AUTOPSY TISSUE , 1977, Journal of neurochemistry.

[106]  J. Goldman,et al.  Synthesis and Turnover of Cytoskeletal Proteins in Cultured Astrocytes , 1984, Journal of neurochemistry.

[107]  M. Shelanski,et al.  Intermediate filaments in nervous tissues , 1978, The Journal of cell biology.

[108]  C. Cotman,et al.  Astrocyte hypertrophy in the Alzheimer's disease hippocampal formation , 1991, Experimental Neurology.

[109]  Y. Sakaki,et al.  Alpha B-crystallin and 27-kd heat shock protein are regulated by stress conditions in the central nervous system and accumulate in Rosenthal fibers. , 1993, The American journal of pathology.

[110]  D. Paulin,et al.  Neurons induce GFAP gene promoter of cultured astrocytes from transgenic mice , 1999, Glia.

[111]  J. Tinklenberg,et al.  Chapter 40: Astrocytic gliosis in the amygdala in Down's syndrome and Alzheimer's disease , 1992 .

[112]  J. Vanderhaeghen,et al.  An acidic protein isolated from fibrous astrocytes. , 1971, Brain research.

[113]  B. González,et al.  Localization of Metallothionein-I and -III Expression in the CNS of Transgenic Mice with Astrocyte-Targeted Expression of Interleukin 6 , 1998, Experimental Neurology.

[114]  L. Mucke,et al.  Astrocyte‐specific expression of hamster prion protein (PrP) renders PrP knockout mice susceptible to hamster scrapie , 1997, The EMBO journal.

[115]  S. Itohara,et al.  Mice devoid of the glial fibrillary acidic protein develop normally and are susceptible to scrapie prions , 1995, Neuron.

[116]  M. Shelanski,et al.  Microtubules and intermediate filaments. , 1976, Essays in biochemistry.

[117]  C. Eliasson Intermediate filaments in astrocytes , 1999 .

[118]  A. Clark,et al.  Neuronal and Glial Gene Expression in Neocortex of Down's Syndrome and Alzheimer's Disease , 1993, Journal of neuropathology and experimental neurology.

[119]  K Suzuki,et al.  Adrenoleukodystrophy. A clinical and pathological study of 17 cases. , 1975, Archives of neurology.

[120]  U. Lendahl,et al.  Abnormal Reaction to Central Nervous System Injury in Mice Lacking Glial Fibrillary Acidic Protein and Vimentin , 1999, The Journal of cell biology.

[121]  Methods : A Companion to Methods in Enzymology , 2022 .

[122]  Brenner,et al.  GFAP Transgenic Mice , 1996, Methods.

[123]  L. Amaducci,et al.  Glial fibrillary acidic protein in cryogenic lesions of the rat brain , 1981, Neuroscience Letters.